Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 7, Issue 280, Pages 280rv2-280rv2
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-03-26
DOI
10.1126/scitranslmed.aaa6853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of CD40-CD154 Costimulatory Pathway Promotes Long-Term Survival of Full-Thickness Porcine Corneal Grafts in Nonhuman Primates: Clinically Applicable Xenocorneal Transplantation
- (2015) H. J. Choi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future
- (2015) Go Woon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Immunomodulation Effects of Mesenchymal Stromal Cells on Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation
- (2015) Ke Zhao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation
- (2015) Michel DuPage et al. IMMUNITY
- Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients
- (2015) Heather Morris et al. Science Translational Medicine
- A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
- (2015) John E Levine et al. Lancet Haematology
- Donor CD4 T Cells Trigger Costimulation Blockade-Resistant Donor Bone Marrow Rejection Through Bystander Activation Requiring IL-6
- (2014) K. Hock et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Administration of Anti-CD20 mAb Is Highly Effective in Preventing but Ineffective in Treating Chronic Graft-Versus-Host Disease While Preserving Strong Graft-Versus-Leukemia Effects
- (2014) Heather F. Johnston et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease
- (2014) Alex F. Herrera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels
- (2014) Chien-Chun Steven Pai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of chronic graft-versus-host disease with bortezomib
- (2014) C.-C. S. Pai et al. BLOOD
- Therapeutic activity of multiple common -chain cytokine inhibition in acute and chronic GVHD
- (2014) A.-K. Hechinger et al. BLOOD
- The biology of graft-versus-host disease: experimental systems instructing clinical practice
- (2014) K. A. Markey et al. BLOOD
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
- (2014) R. Flynn et al. BLOOD
- Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans
- (2014) S. W. Choi et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Acute graft-versus-host disease: a bench-to-bedside update
- (2014) S. G. Holtan et al. BLOOD
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
- (2014) Jason A. Dubovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells
- (2014) Julio Gomez-Rodriguez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
- (2014) Glen A Kennedy et al. LANCET ONCOLOGY
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
- (2014) Alexandra Zanin-Zhorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
- (2014) Bruna Amorin et al. Human Cell
- Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
- (2014) Rosa Bacchetta et al. Frontiers in Immunology
- Vascular Endothelium as a Target of Immune Response in Renal Transplant Rejection
- (2014) Giovanni Piotti et al. Frontiers in Immunology
- Efficacy of Sotrastaurin Plus Tacrolimus AfterDe NovoKidney Transplantation: Randomized, Phase II Trial Results
- (2013) G. R. Russ et al. AMERICAN JOURNAL OF TRANSPLANTATION
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
- (2013) Divya T. Koura et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease
- (2013) S. He et al. BLOOD
- Plasma CXCL9 elevations correlate with chronic GVHD diagnosis
- (2013) C. L. Kitko et al. BLOOD
- Pharmacologic inhibition of PKC and PKC prevents GVHD while preserving GVL activity in mice
- (2013) K. M. K. Haarberg et al. BLOOD
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
- (2013) Jacques Galipeau CYTOTHERAPY
- An Inherently Bifunctional Subset of Foxp3+ T Helper Cells Is Controlled by the Transcription Factor Eos
- (2013) Madhav D. Sharma et al. IMMUNITY
- Development and Maintenance of Regulatory T cells
- (2013) Naganari Ohkura et al. IMMUNITY
- Regulatory dendritic cell therapy: From rodents to clinical application
- (2013) Dalia Raïch-Regué et al. IMMUNOLOGY LETTERS
- Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
- (2013) Marieta Caganova et al. JOURNAL OF CLINICAL INVESTIGATION
- Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
- (2013) Wing-hong Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
- (2013) Sung Won Choi et al. LANCET ONCOLOGY
- Antagonist properties of monoclonal antibodies targeting human CD28
- (2013) Caroline Mary et al. mAbs
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
- (2013) Nicola Gagliani et al. NATURE MEDICINE
- ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
- (2013) Mark T. Vander Lugt et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
- (2013) Tatsuo Kawai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Rituximab in renal transplantation
- (2013) A. Nicholas R. Barnett et al. TRANSPLANT INTERNATIONAL
- Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease
- (2013) Kifah Shahin et al. TRANSPLANTATION
- B-cell targeted therapeutics in clinical development
- (2013) Stephan Blüml et al. ARTHRITIS RESEARCH & THERAPY
- B-Cell-Mediated Strategies to Fight Chronic Allograft Rejection
- (2013) Ali Dalloul Frontiers in Immunology
- Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
- (2012) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation
- (2012) M.-C. Londoño et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
- (2012) N. Poirier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
- (2012) J. E. Levine et al. BLOOD
- The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
- (2012) Alexandre Loupy et al. Nature Reviews Nephrology
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation
- (2012) J. Leventhal et al. Science Translational Medicine
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
- (2012) Pervinder Sagoo et al. Frontiers in Immunology
- Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
- (2011) A. M. Hanash et al. BLOOD
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD
- (2011) J Pidala et al. BONE MARROW TRANSPLANTATION
- Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): Early role for STAT1 and STAT3
- (2011) Hui-Hui Ma et al. CELLULAR IMMUNOLOGY
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-6 Promotes Cardiac Graft Rejection Mediated by CD4+ Cells
- (2011) A. J. Booth et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients
- (2011) J. A. Hutchinson et al. JOURNAL OF IMMUNOLOGY
- Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies
- (2010) R. Sberro-Soussan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses
- (2010) R. Das et al. BLOOD
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
- (2010) J Y Weng et al. BONE MARROW TRANSPLANTATION
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
- (2010) Leandro C. Cerchietti et al. CANCER CELL
- Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
- (2010) I. Tawara et al. CLINICAL CANCER RESEARCH
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
- (2010) Partha S. Biswas et al. JOURNAL OF CLINICAL INVESTIGATION
- Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys
- (2010) Shahrooz S. Kelishadi et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
- (2010) Pervinder Sagoo et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of a B cell signature associated with renal transplant tolerance in humans
- (2010) Kenneth A. Newell et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rejection of the Kidney Allograft
- (2010) Brian J. Nankivell et al. NEW ENGLAND JOURNAL OF MEDICINE
- ECULIZUMAB PREVENTS RECURRENCE OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS) IN RENAL ALLOGRAFTS
- (2010) B. E. Lonze et al. TRANSPLANTATION
- Early Renal Ischemia-Reperfusion Injury in Humans Is Dominated by IL-6 Release from the Allograft
- (2009) D. K. de Vries et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
- (2009) Partow Kebriaei et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
- (2009) L. K. Jasperson et al. BLOOD
- Role of T cells in graft rejection and transplantation tolerance
- (2009) Fadi Issa et al. Expert Review of Clinical Immunology
- Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells
- (2009) Liqing Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
- (2009) J. K. Davies et al. Science Translational Medicine
- Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics
- (2008) E. van Gurp et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
- (2008) P. N. Lalli et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started